Experiences With Smoking Cessation Attempts and Prior Use of Cessation Aids in Smokers With HIV: Findings From a Focus Group Study Conducted in Durham, North Carolina.
Abstract
Cigarette smoking remains disproportionately prevalent and is increasingly a cause
of death and disability among people with HIV (PWH). Many PWH are interested in quitting,
but interest in and uptake of first-line smoking cessation pharmacotherapies are varied
in this population. To provide current data regarding experiences with and perceptions
of smoking cessation and cessation aids among PWH living in Durham, North Carolina,
the authors conducted five focus group interviews (total n = 24; 96% African American) using semistructured interviews. Interviews were recorded,
transcribed, coded, and thematically analyzed. Major themes included ambivalence and/or
lack of interest in cessation; presence of cessation barriers; perceived perceptions
of ineffectiveness of cessation aids; perceived medication side effects; and conflation
of the harms resulting from use of tobacco products and nicotine replacement therapy.
Innovative and effective interventions must account for the aforementioned multiple
barriers to cessation as well as prior experiences with and misperceptions regarding
cessation aids.
Type
Journal articleSubject
HumansHIV Infections
Focus Groups
Health Behavior
Smoking Cessation
Qualitative Research
Adolescent
Adult
Aged
Middle Aged
African Americans
North Carolina
Female
Male
Interviews as Topic
Smokers
Tobacco Use Cessation Devices
Permalink
https://hdl.handle.net/10161/23700Published Version (Please cite this version)
10.1521/aeap.2021.33.2.158Publication Info
Pacek, Lauren R; Holloway, Alicia D; Cropsey, Karen L; Meade, Christina S; Sweitzer,
Maggie M; Davis, James M; & Joseph McClernon, F (2021). Experiences With Smoking Cessation Attempts and Prior Use of Cessation Aids in Smokers
With HIV: Findings From a Focus Group Study Conducted in Durham, North Carolina. AIDS education and prevention : official publication of the International Society
for AIDS Education, 33(2). pp. 158-168. 10.1521/aeap.2021.33.2.158. Retrieved from https://hdl.handle.net/10161/23700.This is constructed from limited available data and may be imprecise. To cite this
article, please review & use the official citation provided by the journal.
Collections
More Info
Show full item recordScholars@Duke
James Davis
Associate Professor of Medicine
Dr. James Davis is a practicing physician of Internal Medicine, and serves as the
Medical Director for Duke Center for Smoking Cessation, Director of the Duke Smoking
Cessation Program and Co-Director of the Duke-UNC Tobacco Treatment Specialist Credentialing
Program. His research focuses on development of new pharmaceutical treatments for
smoking cessation. He is principal investigator on several trials including a study
on “adaptive” smoking cessation and several trials
Christina S. Meade
Visiting Associate Prof of Psychology & Neuroscience
Dr. Meade’s domestic research program focuses on predictors of HIV risk behavior in
adults with substance use and psychiatric disorders, and the relationship between
neuropsychiatric conditions and continued risk behavior in HIV-positive adults. She
is particularly interested in how drug addiction and HIV infection impact executive
functions, such as decision making, that lead individuals to engage in risky behaviors. Many
of her current projects incorporate MRI to isolate the effe
Lauren R Pacek
Assistant Professor in Psychiatry and Behavioral Sciences
Alphabetical list of authors with Scholars@Duke profiles.

Articles written by Duke faculty are made available through the campus open access policy. For more information see: Duke Open Access Policy
Rights for Collection: Scholarly Articles
Works are deposited here by their authors, and represent their research and opinions, not that of Duke University. Some materials and descriptions may include offensive content. More info